Sign in
8-K

Current Report

Vanda Pharmaceuticals Inc. Filed Acc 0000950133-08-004078

Exit or restructuring costs · Executive or director change · Bylaws or fiscal year change

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading w72005e8vk.htm…